Aarti Pharmalabs Limited (NSE: AARTIPHARM), ISIN INE0LRU01027 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
AARTIPHARM last traded at ₹679.95 (-0.42%), with a 52-week range of ₹583.85 to ₹952.00 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 42.86%, FIIs 8.17%, DIIs 7.22%, mutual funds 0.79%.
EquiSense Score (ECS): 52/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.